Island Pharmaceuticals applied for quotation of 690,000 new fully paid ordinary shares on the ASX following the exercise of existing options. The shares were issued at $0.21 each, representing a modest increase in the company’s total share capital rather than a new fundraising effort. The company confirmed it remains compliant with disclosure requirements and that no additional material information has been withheld from the market.
